Stroke has become the second leading cause of long-term disability and the second cause of death worldwide.1 Annually, 15 million people suffer a stroke. Of these, 5 million die and another 5 million are left permanently disabled, placing a burden on their family and community.2

A stroke happens when the blood supply to part of the brain is suddenly interrupted (ischemic stroke) or when a blood vessel in the brain bursts, spilling blood into the spaces surrounding brain cells (haemorrhagic stroke).3 In Western societies, about 80% of strokes caused by focal cerebral ischemia due to arterial occlusion, and the remaining 20% are caused by haemorrhages.4

Shortages of oxygen and nutrients lead to brain cells death. Although stroke is a disorder of the brain, it can affect the entire body and may cause following problems:

  • Complete paralysis on one side of the body, called hemiplegia
  • Hemiparesis is a weakness of one  side of the body
  • Trouble with walking, loss of balance or coordination
  • Problems with thinking, awareness, attention, learning, judgment, and memory
  • Stroke survivors often have problems understanding or forming speech.
  • Stroke patients may have difficulty controlling their emotions or may express inappropriate emotions.
  • Post-stroke depression
  • Vascular dementia

Cerebrolysin® belongs to agents with neuroprotection and neurorecovery functions used in the acute phase and post-stroke rehabilitation and it is recommended that its administration should be initiated as early as possible, usually within a few hours post-stroke. Beneficial results were shown in many studies.